US forces still in ‘defensive posture' in Mideast: White House
Trump's brief warning on social media, without further details, raised speculation that the United States may be readying to join Israel in attacking Iran.
Those suspicions rose further after it was announced that Trump would be leaving a G7 summit in Canada and returning to the White House a day early over the mounting Middle East conflict.
But White House and Pentagon officials reiterated that US forces in the region remained in a 'defensive' posture.
White House spokesperson Alex Pfeiffer, replying to a post on social media that claimed the United States was attacking in Iran, said: 'This is not true.'
'American forces are maintaining their defensive posture, and that has not changed,' he said.
Pentagon Chief Pete Hegseth similarly told Fox News in a televised interview that 'we are postured defensively in the region, to be strong, in pursuit of a peace deal, and we certainly hope that's what happens here.'
Earlier in the day, Hegseth had announced that he had 'directed the deployment of additional capabilities' over the weekend to the Middle East.
'Protecting US forces is our top priority and these deployments are intended to enhance our defensive posture in the region,' he wrote on X.
His post on social media came after the aircraft carrier USS Nimitz was tracked leaving Southeast Asia on Monday, and amid reports that dozens of US military aircraft were heading across the Atlantic.
A US defense official, speaking on condition of anonymity, confirmed that Hegseth had ordered the Nimitz Carrier Strike Group to the Middle East, saying it was 'to sustain our defensive posture and safeguard American personnel.'
The movement of one of the world's largest warships came on day four of the escalating air war between Israel and Iran, with no end in sight despite international calls for de-escalation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Straits Times
13 minutes ago
- New Straits Times
Trump wants to extend federal control over Washington police
WASHINGTON: US President Donald Trump said on Wednesday he would ask the Republican-controlled Congress to extend federal control of Washington's city police force beyond 30 days, escalating his campaign to exert presidential power over the nation's capital. Trump also asserted that any congressional action could serve as a model for other US cities. He has previously threatened to expand his efforts to other Democratic-run cities such as Chicago that he claims have failed to address crime. The Republican president's extraordinary moves in Washington are reflective of how he has approached his second term in office, shattering political norms and legal concerns to test the limits of his office's power. It was not clear how Trump's takeover of Washington's Metropolitan Police Department could be replicated elsewhere. In seizing control on Monday, Trump took advantage of a federal law, the District of Columbia Home Rule Act, that permits the president to do so under emergency circumstances for up to 30 days. There is no basis for Trump to attempt similar takeovers in other cities, according to John P. Fishwick Jr., a former federal prosecutor in Virginia, who said that Washington represents a "unique situation." Trump also announced on Monday that he was deploying 800 National Guard troops to the city, a tactic he employed in Los Angeles in June when he mobilized thousands of Guard soldiers and US Marines over the objections of state and local officials in response to protests over his administration's immigration raids. Separately, hundreds of federal officers and agents from more than a dozen agencies have fanned out across Washington in recent days. Trump has painted a picture of the US capital as a city gripped by a wave of crime and pervasive homelessness, despite both federal and city crime statistics showing that violent crime has declined precipitously since a spike in 2023. Trump said on Wednesday that the city's crime statistics were a "total fraud," without providing evidence, and that the public would soon see a "big change" in the figures. US Attorney General Pam Bondi told FOX Noticias that officials were looking into whether the city's statistics last year were manipulated. HUNDREDS OF OFFICERS ON PATROL The office of Washington Mayor Muriel Bowser, a Democrat, declined to respond on Trump's latest comments. Bowser has sought to strike a diplomatic tone in recent days while also noting that violent crime in the city hit a 30-year low last year. Still, as big US cities go, Washington remains more dangerous than many others based on its homicide rate. In 2024, there were about 26 homicides per 100,000 residents, according to crime data compiled from 36 of the largest US cities by the non-partisan Washington-based Council on Criminal Justice. Only four of the 36 had higher homicide rates: Baltimore, Detroit, Memphis and St. Louis. It is not yet clear what the takeover of Washington's police force means in practice. Chief Pamela Smith has framed the federalization of her department as a collaborative partnership with federal law enforcement agencies, rather than a direct federal takeover, and says she still answers to Mayor Bowser. More than 1,450 law enforcement personnel were on patrol in Washington on Tuesday night, a White House official said, including 30 National Guard troops and 750 city police officers. The official said the White House expects a "significantly higher" Guard presence on Wednesday night. The effort has resulted in 103 arrests since Aug. 7, including 43 on Tuesday, the official said. The charges include one homicide charge, 33 firearms charges and 23 immigration charges, the official said, and have led to 24 seized firearms. During the same period in 2024, the Metropolitan Police Department arrested 364 people in total, police data shows, including traffic and liquor law violations as well as murder, prostitution, carjacking, assault, theft, burglary and robbery. The MPD made 20,386 adult arrests in 2024, an average of 56 arrests a day, or nearly three times the rate cited by the White House. The Metropolitan Police Department and the FBI on Wednesday both referred questions seeking more details on the arrests to the White House, a highly unusual deflection that signaled the White House's outsized role in overseeing the law enforcement crackdown. TRUMP THREATENS EMERGENCY DECLARATION Asked about Trump's call for congressional action, the offices of House Speaker Mike Johnson and Senate Majority Leader John Thune, both Republicans, pointed to social media posts on Monday expressing support for Trump's actions. Any legislation to extend Trump's control over the police department would likely stall in the Senate, where Democrats can use procedural rules to block most bills. Trump told reporters on Wednesday that if Congress fails to act, he can declare a "national emergency" to extend the 30-day limit, though legal experts expressed skepticism. "There's nothing about the president extending past 30 days unilaterally," Claire Finkelstein, a University of Pennsylvania law professor, said of the Home Rule Act. "If the 30 days are up, that's that." The president has used emergency declarations to justify numerous unprecedented executive actions, including historically high tariffs on foreign imports and his wide-ranging immigration crackdown. Many have drawn lawsuits challenging his authority. — REUTERS
New Straits Times
43 minutes ago
- New Straits Times
US pharma tariffs likely weeks away, sources say
WASHINGTON: The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new sector-specific US tariffs likely remains weeks away, four official and industry sources said, later than initially promised as he focuses on other matters. Commerce Secretary Howard Lutnick had said in April when the review of whether reliance on foreign drug production threatens US national security was launched that he anticipated that it would conclude between mid-May and mid-June. Global pharmaceutical companies are bracing for the outcome of the investigation, which will usher in sector-specific tariffs that Trump has said could start small and eventually rise to 250 per cent. The Republican president said as recently as last week that his plan relies on phased-in tariffs, giving drugmakers time to increase manufacturing in the United States as he pushes to alter what he says are global trade distortions in many industries. One government official in Europe and a source with knowledge of the White House process, as well as two sources at European drug firms familiar with the process, told Reuters that the report and tariffs announcement was not imminent and likely weeks away. These sources spoke on condition of anonymity. A White House spokesperson, asked about media reporting indicating that the results of the probe could be several weeks away, cautioned that such reports were pure speculation unless confirmed by the White House. The spokesperson declined to give further details about the timing of the pharma probe or one involving semiconductors. The investigation is examining pharmaceutical imports ranging from finished prescription drugs to active pharmaceutical ingredients, called APIs, and other raw materials, with the results to be disclosed in a Commerce Department report. Lutnick said last month the tariff plan that will be based on the report would be completed by the end of July. Lutnick then said on July 29 it would be two more weeks. The investigation was launched under Section 232 of the Trade Expansion Act of 1962. While the investigation is ongoing, the pharmaceutical sector has been exempted from the sweeping tariffs imposed by the Trump administration. The United States has reached bilateral trade deals with the UK, Japan, South Korea and the European Union that promised more favorable terms for their pharma exports than those expected to be levied on the sector globally. A European government official said that an announcement before the end of August appears unlikely but cautioned that the timeline could shift depending on other developments. A source at a European drugmaker said the Trump administration is focused on the US-Russia summit in Alaska on Friday and therefore no announcement is expected this week. The source familiar with the White House process said that announcement is unlikely to come this week given other priorities. That source and one other source said that they expect the Trump administration to announce the results of its national security investigation into semiconductors first, followed by the pharma announcement, putting it a few weeks away. The Section 232 provision authorizes the president to adjust imports - including imposing tariffs - if a category of goods is being imported into the United States in quantities that "threaten or impair the national security." Medical goods historically have been spared from trade wars due to the potential harm to patient access, and drugmakers have said tariffs could undercut other health policy goals outlined by the Trump administration, including lowering drug prices. US tariffs on imported pharmaceutical products would mark the latest in a series of sectoral tariffs announced by the administration, following metals and cars, that some economists have predicted will drive up costs for American consumers.
The Sun
an hour ago
- The Sun
US appeals court lets Trump cut billions in foreign aid
WASHINGTON: A federal appeals court on Wednesday lifted an injunction that required the U.S. State Department to continue making foreign aid payments, handing a victory to President Donald Trump. In a 2-1 decision, a three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit said a lower court erred by ordering the Trump administration to restore foreign assistance payments previously approved by Congress. Trump imposed a 90-day pause on all foreign aid on January 20, the same day he was inaugurated for a second term in the White House. His executive order was followed by aggressive moves to gut USAID, the main U.S. foreign aid agency, including by placing much of its staff on leave and exploring bringing the formerly independent agency under the State Department. Two nonprofit groups that receive federal funding, AIDS Vaccine Advocacy Coalition and Journalism Development Network, brought litigation alleging Trump's funding freeze was unlawful. U.S. District Judge Amir Ali, an appointee of former President Joe Biden, ordered the Trump administration to pay nearly $2 billion in outstanding aid to its humanitarian partners worldwide. Writing for the two-judge majority, Circuit Judge Karen Henderson said the nonprofit groups 'lack a cause of action to press their claims' and therefore failed to satisfy the requirements for an injunction. Henderson wrote that only the U.S. Government Accountability Office, a watchdog agency, could challenge the president's efforts to withhold foreign aid funding. Henderson, who was appointed to the appeals court by President George H.W. Bush, said the court was not addressing the question of whether Trump's foreign aid freeze violated the U.S. Constitution by infringing on the spending power of Congress. Henderson's opinion was joined by Circuit Judge Gregory Katsas, a Trump appointee. Circuit Judge Florence Pan, a Biden appointee, wrote in a dissenting opinion that her colleagues were allowing the Trump administration to disregard federal law and the separation of powers outlined in the Constitution. 'The court's acquiescence in and facilitation of the Executive's unlawful behavior derails the carefully crafted system of checked and balanced power that serves as the greatest security against tyranny - the accumulation of excessive authority in a single Branch,' Pan wrote. A spokesperson for the Office of Management and Budget, the White House's budget office, said the ruling stops 'radical left dark money groups' from 'maliciously interfering with the president's ability to spend responsibly and to administer foreign aid in a lawful manner in alignment with his America First policies.'- REUTERS
